Sign in
Enrolling by invitationNo phase

Mobile App-Based Infection Monitoring in Familial Mediterranean Fever

Key facts

Who runs it
Istanbul University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
40 people, planned
Started
5 Nov 2025
Planned end
15 Jul 2026
Type of study
Observational
Treatments tested
  • mobile application
Record updated
3 December 2025

Who can take part

Age
8 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Children and adolescents aged 8-18 years
  • FMF diagnosis established by Tel Hashomer and/or Eurofever criteria
  • Regular follow-up at the participating pediatric rheumatology clinic
  • Stable treatment regimen, defined as:
  • Colchicine use for ≥ 4 weeks
  • Biologic or other anti-inflammatory agents stable for ≥ 8 weeks (if applicable)
  • Access to a smartphone or tablet (iOS/Android) with internet and ability to use the study mobile application (caregiver assistance allowed)
  • Language proficiency (patient and/or caregiver) sufficient to use the app and respond to prompts
  • Informed consent from a parent/guardian and assent from the child, as appropriate

Who cannot take part

  • Known primary or secondary immunodeficiency or ongoing immunosuppressive chemotherapy outside standard FMF care
  • Concurrent participation in another clinical study likely to affect outcomes or reporting
  • Co-existing chronic inflammatory or autoimmune disorders that may confound flare/infection assessment (e.g., JIA, IBD, Behçet disease) other than FMF
  • Chronic active infection (e.g., TB, HBV, HCV, HIV) or acute febrile illness at enrollment precluding baseline assessment
  • Cognitive, visual, or motor limitations preventing app use without caregiver support
  • No reliable access to a compatible device or internet connection
  • Anticipated non-adherence (e.g., inability to complete app entries) as judged by the investigator
  • Refusal or withdrawal of consent/assent

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 18 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Familial Mediterranean Fever (FMF) is an autoinflammatory disease characterized by recurrent episodes of fever, abdominal pain, and serositis. FMF attacks often present with fever and systemic symptoms resembling infectious diseases, making it challenging in clinical practice to distinguish between an attack and an infection. Moreover, infections are known to trigger FMF attacks; however, the number of prospective studies evaluating this association remains limited.

Read full original descriptionShow less

In the current literature, the frequency of attacks and triggering factors in FMF patients have mostly been assessed through retrospective chart reviews. Such methods are prone to incomplete or recall-based data regarding the onset of attacks and infection-related symptoms. With the growing availability of digital health applications, it has become possible to record disease symptoms in real time and on a regular basis, providing more reliable data for both clinicians and researchers.

The present study aims to prospectively evaluate the relationship between infections and disease flares in FMF patients by systematically recording infection symptoms and attack characteristics through a mobile application. This approach is intended to achieve a better understanding of the infection-flare association, improve patient management, and prevent unnecessary treatments. In addition, the feasibility of mobile application-based patient monitoring will be assessed, and its potential contribution to routine clinical practice will be explored.

The group in the trial

  • FMF group

    Patients aged 6-18 years with a diagnosis of FMF according to the Tel Hashomer and Eurofever criteria who agreed to use the mobile application

    Treatment: mobile application

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Monitoring Infection Symptoms Through a Mobile Application and Their Effect on Disease Flares in Familial Mediterranean Fever Patients
Criteria questions
Built from NCT07212764, who can take part
Record updated
3 December 2025